Abstract
Optimal blood glucose control and the restoration of physiological insulin secretion is an ongoing medical challenge. Continuous subcutaneous insulin infusion (CSII) aims to restore blood glucose levels and reduce the frequency of hypoglycaemic events. Its benefits include a better glycaemic profile compared with management involving multiple daily insulin injections and giving individuals more flexibility in their everyday lives. The advantages of insulin pumps include basal delivery consistency, adjustable basal rates and low insulin depots. However, experience with CSII indicates that candidates should be selected carefully, be well educated in how use the device and be highly motivated to improve their blood glucose control.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.